[go: up one dir, main page]

PE20091690A1 - Peptidos derivados del transcrito regulado por cocaina y anfetamina (cart) y formulaciones que los contienen - Google Patents

Peptidos derivados del transcrito regulado por cocaina y anfetamina (cart) y formulaciones que los contienen

Info

Publication number
PE20091690A1
PE20091690A1 PE2009000423A PE2009000423A PE20091690A1 PE 20091690 A1 PE20091690 A1 PE 20091690A1 PE 2009000423 A PE2009000423 A PE 2009000423A PE 2009000423 A PE2009000423 A PE 2009000423A PE 20091690 A1 PE20091690 A1 PE 20091690A1
Authority
PE
Peru
Prior art keywords
cart
human
cocaine
amphetamine
peptide
Prior art date
Application number
PE2009000423A
Other languages
English (en)
Inventor
Jan Albert Gossen
Johannes Petrus Leonardus Gerrits
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of PE20091690A1 publication Critical patent/PE20091690A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

REFERIDA A UN PEPTIDO DERIVADO DEL TRANSCRITO REGULADO POR COCAINA Y ANFETAMINA (CART) QUE TIENE LA ACTIVIDAD BIOLOGICA DEL CART HUMANO SELECCIONADO DE CART55-102 DE RATA, CART61-102 DE RATA, CART62-102 DE RATA, CART42-89 HUMANO, CART48-89 HUMANO Y CART49-89 HUMANO, DONDE DICHO PEPTIDO SE ENCUENTRA DENTRO DE UNA MATRIZ POLIMERICA BIODEGRADABLE FORMANDO PARTE DE UNA FORMULACION DE LIBERACION LENTA QUE TIENE LA FORMA DE UN IMPLANTE SUBCUTANEO O DE UN ANILLO VAGINAL. DICHO PEPTIDO ES UTIL EN EN EL AUMENTO DE LA DENSIDAD MINERAL OSEA (DMO)
PE2009000423A 2008-03-20 2009-03-20 Peptidos derivados del transcrito regulado por cocaina y anfetamina (cart) y formulaciones que los contienen PE20091690A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08005279 2008-03-20

Publications (1)

Publication Number Publication Date
PE20091690A1 true PE20091690A1 (es) 2009-11-13

Family

ID=39744830

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2009000423A PE20091690A1 (es) 2008-03-20 2009-03-20 Peptidos derivados del transcrito regulado por cocaina y anfetamina (cart) y formulaciones que los contienen

Country Status (18)

Country Link
US (1) US20100075893A1 (es)
EP (1) EP2265280A2 (es)
JP (1) JP2011515363A (es)
KR (1) KR20100135751A (es)
CN (1) CN101977624A (es)
AR (1) AR071010A1 (es)
AU (1) AU2009226966A1 (es)
BR (1) BRPI0908423A2 (es)
CA (1) CA2717459A1 (es)
CL (1) CL2009000675A1 (es)
CO (1) CO6290697A2 (es)
IL (1) IL207542A0 (es)
MX (1) MX2010010016A (es)
PE (1) PE20091690A1 (es)
RU (1) RU2010142903A (es)
TW (1) TW201000117A (es)
WO (1) WO2009115525A2 (es)
ZA (1) ZA201006004B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103030689B (zh) * 2012-12-27 2014-09-24 无锡米度生物技术有限公司 一种cart多肽化合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9522403D0 (en) * 1995-11-01 1996-01-03 Hoechst Roussel Ltd Intravaginal drug delivery device
JP2002538757A (ja) * 1997-03-26 2002-11-12 ノボ ノルディスク アクティーゼルスカブ 食欲制御活性を有するポリペプチド
US20070203058A1 (en) * 2003-09-19 2007-08-30 Novo Nordisk A/S Novel Glp-1 Derivatives
ITMI20061545A1 (it) * 2006-08-02 2008-02-03 Mediolanum Pharmaceuticals Ltd Particelle in grado di rilasciare il principio attivo per un periodo prolungato di tempo

Also Published As

Publication number Publication date
CN101977624A (zh) 2011-02-16
RU2010142903A (ru) 2012-04-27
KR20100135751A (ko) 2010-12-27
CO6290697A2 (es) 2011-06-20
TW201000117A (en) 2010-01-01
EP2265280A2 (en) 2010-12-29
US20100075893A1 (en) 2010-03-25
MX2010010016A (es) 2010-09-30
CA2717459A1 (en) 2009-09-24
IL207542A0 (en) 2010-12-30
AR071010A1 (es) 2010-05-19
AU2009226966A1 (en) 2009-09-24
JP2011515363A (ja) 2011-05-19
WO2009115525A3 (en) 2010-03-18
ZA201006004B (en) 2011-05-25
BRPI0908423A2 (pt) 2015-08-04
CL2009000675A1 (es) 2009-08-07
WO2009115525A2 (en) 2009-09-24

Similar Documents

Publication Publication Date Title
CL2013000423A1 (es) Forma de dosificacion farmaceutica con resistencia a rompimiento de al menos 500 n, que contiene un ingrediente activo, un polisacarido anionico y un oxido de polialquileno, en donde el ingrediente activo esta presente en una matriz de liberacion controlada comprendiendo el polisacarido anionico y el oxido de polialquileno.
IN2012DN00570A (es)
PE20091184A1 (es) Formas de dosificacion farmaceutica
AR054683A1 (es) Capuchon para dispositivos para la administracion de farmacos
GT200500384A (es) Formas de dosificacion farmaceutica solidas administrables por via oral con liberacion modificada
UA105496C2 (uk) Доставка октреотиду сухими фармакологічними формами
WO2011011285A3 (en) Biologically active sutures for regenerative medicine
GT200900211A (es) Composicion del antitranspirante/desodorante
GT200200242A (es) Composiciones polimeras de liberacion controlada de compuestos que promueven el crecimiento oseo
CL2008003063A1 (es) Compuestos derivados de 1,3,4-tiadiazol espiro condensado, inhibidores de la actividad quinesina ksp; composicion farmaceutica; y su uso en el tratamiento de enfermedades proliferativas tales como el cancer, hiperplasia, hipertrofia cardiaca, enfermedades autoinmune, trastornos fungicos, artritis, rechazo a imjertos, entre otras.
MX2012007210A (es) Implante removible degradable para la liberacion sostenida de un compuesto activo.
PE20071139A1 (es) Formulacion de liberacion sostenida que comprende octreotida y dos o mas polimeros de polilactido-co-glicolido
MX2022005374A (es) Composicion de jabon.
CL2008003489A1 (es) Composicion de microcapsulas de copolimero lactico-co-glicolico (plga) o copolimero lactico co-glicolico y polietilenglicol (plga-peg) comprendiendo somatostatina o un analogo del mismo; y su uso para tratar y/o prevenir la diarrea.
AR079750A2 (es) Comprimidos bucodispersables y metodo de fabricacion
PE20090387A1 (es) Formulacion de pasireotida
PE20091690A1 (es) Peptidos derivados del transcrito regulado por cocaina y anfetamina (cart) y formulaciones que los contienen
UY29250A1 (es) Agentes citotóxicos que comprenden nuevos taxanos modificados en c-2.-
MX2009001231A (es) Implantes subcutaneos que liberan un principio activo durante un periodo de tiempo extendido.
WO2014060443A3 (en) A composite scaffold for use as a tissue engineering implant
BRPI0519022A2 (pt) formaÇço insitu de implante para animais
BR112016015985A2 (pt) Composição e métodos de preparação da composição e de fornecimento de substância personalizadora à pele de indivíduos
CO6390100A2 (es) Composiciones con liberación rápida de fármaco
NI201400066A (es) Anillo vaginal que comprende meloxicam y un agente modulador de la libración del principio activo, útil como anticonceptivo de uso continuo en mujeres
MX2009001232A (es) Implantes subcutaneos que liberan un principio activo en un periodo de tiempo extendido.

Legal Events

Date Code Title Description
FD Application declared void or lapsed